Latest filing published 22 Nov 2024 for BIODESIX INC, €38k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Lawrence T. Kennedy Jr.: trading record in brief
This profile gathers the share dealings of Lawrence T. Kennedy Jr. in Biodesix Inc. Between 21 November 2022 and 21 November 2024, the trades on record add up to 8 filings.
The open-market record is one-sided, with 5 purchases worth €12.2M and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 1 share grant and 2 option exercises. 2024 to date brings 3 purchases and no sales.
A typical purchase (the median) is worth €64k. Of 5 purchases, 5 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.
The newest entry dates from 22 November 2024: an open-market purchase of €38k, in Biodesix Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Lawrence T. Kennedy Jr.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 35,000 shares@ US$1.15890.2% of flowCommon StockSEC:0000905148-24-003257:0Canonical exit: 19 Feb 2025 (T+90)
- 51,200 shares@ US$1.3650.3% of flowCommon StockSEC:0000905148-24-002946:0Canonical exit: 3 Feb 2025 (T+90)
- 1,739,120 sharesCommon StockSEC:0000905148-24-001610:0
- 6,172,839 shares@ US$1.6249.5% of flowCommon StockSEC:0000905148-23-000623:0
- 8,260,869 shares@ US$1.1549.9% of flowCommon StockSEC:0001140361-23-000723:0Canonical exit: 19 Feb 2023 (T+90)
5 of 5 declarations
